(Q44454640)

3 December 2017

title

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial (English)

1 reference

randomized controlled trial

3 December 2017

main subject

1 reference

1 reference

Bankole A Johnson

1 reference

3 December 2017

Nassima Ait-Daoud

1 reference

3 December 2017

Charles L Bowden

1 reference

3 December 2017

Carlo C DiClemente

1 reference

3 December 2017

John D Roache

1 reference

3 December 2017

Kevin Lawson

1 reference

3 December 2017

Martin A Javors

1 reference

3 December 2017

Jennie Z Ma

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

361

1 reference

3 December 2017

issue

9370

1 reference

3 December 2017

page(s)

1677-1685

1 reference

Behavioral neurobiology of alcohol addiction: recent advances and challenges.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Ethanol and negative feedback regulation of mesolimbic dopamine release in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Glutamate-mediated transmission, alcohol, and alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Topiramate blocks kainate-evoked cobalt influx into cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Alcoholism: a controlled trial of "treatment" and "advice"

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Psychometric properties and validity of the obsessive-compulsive drinking scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Testing for baseline balance in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Clinical pharmacology of topiramate: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913370-3

7 January 2021

10.1016/S0140-6736(03)13370-3

Identifiers

DOI

1 reference

3 December 2017

1 reference